FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease Mário Reis Álvares-da-Silva; Márcia da Silva Vargas; Soheyla Mohd Souza Rabie; Gabriella Jonko; Patricia Gabriela Riedel; Larisse Longo; Marcelo Rodrigues Gonçalves; Vivian Cristine Luft; Dvora Joveleviths;

Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;

Validation of the Hepamet fibrosis score in a multi-ethnic Asian population Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;